RIV Capital Inc (RIV.CX)
0.13
0.00 (0.00%)
CAD |
CNSX |
May 17, 16:00
RIV Capital Shareholders Equity (Quarterly): 125.57M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 125.57M |
| June 30, 2023 | 131.21M |
| March 31, 2023 | 147.18M |
| December 31, 2022 | 186.45M |
| September 30, 2022 | 205.55M |
| June 30, 2022 | 247.62M |
| March 31, 2022 | 330.42M |
| December 31, 2021 | 347.29M |
| September 30, 2021 | 350.22M |
| June 30, 2021 | 280.92M |
| March 31, 2021 | 312.60M |
| Date | Value |
|---|---|
| December 31, 2020 | 302.46M |
| September 30, 2020 | 218.91M |
| June 30, 2020 | 306.39M |
| March 31, 2020 | 298.21M |
| December 31, 2019 | 335.02M |
| September 30, 2019 | 373.50M |
| June 30, 2019 | 402.17M |
| March 31, 2019 | 408.03M |
| December 31, 2018 | 292.40M |
| September 30, 2018 | 366.51M |
| March 31, 2018 | 192.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
125.57M
Minimum
Sep 2023
402.17M
Maximum
Jun 2019
272.32M
Average
300.33M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biocure Technology Inc | 1.603M |
| Core One Labs Inc | 5.641M |
| Nova Mentis Life Science Corp | -0.601M |
| Nanosphere Health Sciences Inc | -2.064M |
| Lobe Sciences Ltd | -1.235M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 340.84M |
| Total Liabilities (Quarterly) | 215.27M |
| Debt to Equity Ratio | 1.119 |
| Current Ratio | 18.40 |
| Net Debt Paydown Yield | -17.01% |